The structural assignments of a number of bicyclic alkaloids isolated from frogs have been reassigned or questioned after synthesis of the proposed structures. Herein we report a practical and short formal synthesis of the 5-alkylindolizidine core, from readily available α-amino acids or homoserine that could be utilized to support structural assignments.
The structural assignments of a number of alkaloids isolated in small quantities from frogs have recently been corrected or reassigned [1] . The original structural assignments were made by analyses of mass spectral fragmentation patterns [1] and authentic material was not readily available in order to support the structural assignments. Even though there have been numerous reports of methods to synthesize alkylated indolizidines [2] the methods are often lengthy and not amenable to rapid delivery of products. What would be desirable is a rapid and flexible method to access these compounds quickly to assist with structural assignments. Recently we reported a rapid synthesis of indolizidines from γ-lactones [3] including the structure originally proposed for the 5-alkyl derivative indolizidine 209D in four steps from commercially available γ-decanolactone. The key step was the formation of a γ-pyrrolic ester by ring opening of the lactone with pyrrole. The lack of availability of many of the lactones required to synthesize other derivatives such as indolizidine 167B led us to develop an alternative strategy. We recently reported an efficient and mild method for the synthesis of pyrroles from α-amino esters [4] and this provided a launching pad for rapid entry into the 5-alkylindolizidine skeleton.
The key to our proposed synthesis of 5-alkyl indolizidines was the conversion of α-pyrrolic esters to γ-pyrrolic esters through a two-carbon chain homologation. This could be achieved by DIBAL-H reduction of the ester to an aldehyde followed by in situ Wadsworth-Emmons olefination [5] . For our preliminary studies we decided to develop the synthetic method on the readily available α-pyrrolic ester 1 derived from DL-alanine ( Figure 1 ). While there are no known 5-methyl indolizidine natural products, there are substituted indolizidine natural products that contain a methyl substituent at the 5 position [1] .
Therefore the α-pyrrolic ester 1 was reduced to the aldehyde using DIBAL-H at -78ºC in dichloromethane. Addition of a solution of the sodium salt of triethylphosphonoacetate in THF and warming to room temperature gave the acrylate derivative 2 in 73% yield. When the ratio of THF:dichloromethane was ≥ 1:3 only the trans isomer of 2 was observed, whereas when the ratio of solvents was < 1:3 some cis isomer was observed. While the intermediate aldehyde has been isolated previously [6] we found it convenient, with no detriment to yield, to carry out the in situ olefination. Hydrogenation of the alkene yields the desired γ-pyrrolic ester 3 in excellent yield. The boron tribromide mediated cyclization of 3 gave the known 5-methyl-6,7-dihydroindolizidin-8(5H)-one (4) which had previously been transformed into the ant pheromone monomorine [3] . Therefore, in four steps starting from commercially available materials, we have synthesized the indolizidine core with a selected substituent at C-5. Catalytic hydrogenation of compounds similar to compound 4 has been shown to proceed stereoselectively to yield the desired 5-alkylindolizidines [3, 7] . This synthesis of 5-alkylindolizidines is dependant on the availability of the appropriately substituted α-amino acids. For example, racemic indolizidine 167B, which has an n-propyl substituent at C-5, could be synthesized from DL-norvaline. Following the same procedure as that established for alanine the indolizidine derivative 7 (R = n-C 3 H 7 ) was formed in ~65% over 4 steps from the amino acid.
Hydrogenation of 7 has been reported to give the structure proposed for indolizidine 167B [8] so our work represents a formal synthesis of this alkaloid. In the same manner DL-norleucine was converted into 7 (R = n-C 4 H 9 ) which contains the same alkyl sidechain as that found in the 5,8-dialkyl derivatives indolizidines 195I and 223J [1] . The limitation to the method is a reliance on the availability of the appropriately substituted amino acid starting material. Higher amino acid homologs, that would be required to introduce a pentyl or hexyl substituents, are available but only in racemic form. The individual enantiomers required for an asymmetric synthesis are not readily available unlike alanine and norvaline. A method that has the potential to yield either enantiomer of the desired 5-alkylindolizidine is desirable. We envisaged that serine or its derivatives could be used as a template that could be chain extended via cuprate chemistry. The chain extension by the use of cuprate chemistry of a protected serine derivative has previously been reported [9] . We proposed to protect the amine as a pyrrole and then to mesylate the hydroxy substituent followed by chain extension. We have previously reported the synthesis of the pyrrole 8 (89% yield; 99% ee) from serine [4] . However, all attempts to form the mesylate from 8 resulted in dehydration to give the dehydroalanine derivative 12 (Scheme 3). Even when the protection of the alcohol as a benzyl ether was attempted, so that two-carbon homologation could be performed first, the undesired elimination occurred. Although the achiral dehydroalanine derivative 12 could itself be used in chain homologation via a conjugate addition with a cuprate, this would defeat the purpose of using a chiral amino acid starting material, which was to allow for stereochemical control. We therefore sought to replace the problematic β-hydroxy ester 8 with the corresponding γ-hydroxy derivative. Both enantiomers of homoserine (13) are commercially available or can be readily synthesized from methionine [10] . Homologation to a γ-pyrrolic ester would give an advanced intermediate that would require only three steps to give any of the longer chain 5-alkylindolizidines. The present study used racemic homoserine to obtain proof of concept.
The synthesis of the corresponding pyrrole from (±)-homoserine occurred smoothly to give the α-pyrrolic lactone 14 in 65% yield. Reduction and in-situ Wadsworth-Emmons olefination gave the crude α, β-unsaturated ester 15 which was immediately hydrogenated to give the required γ-pyrrolic ester 16 in 55% yield. Mesylation of the hydroxyl group then gave a template 17 that could be reacted with a variety of alkyl cuprates to give the required γ-pyrrolic ester derivatives. To test the chemistry, the 6-hexyl indolizidine (indolizidine 209D) was targeted. Addition, to 17, of the cuprate derived from n-butyl lithium gave 18 in 46% yield (reaction conditions not optimized). The ester 18 was cyclized using boron tribromide to give 5-n-hexyl-6,7-dihydroindolizidin-8(5H)-one (19) which we have previously hydrogenated to give racemic indolizidine 209D [3] .
In conclusion we have developed a rapid procedure to access the core skeleton of 5-alkyl indolizidines from α-amino acids. These compounds can be converted to the mono substituted indolizidines or act as templates to access more complex derivatives as previously shown [3] . We are currently developing the asymmetric synthesis as well as using these intermediates to access other di-and tri-alkylated indolizidines.
Experimental
General: 1 H and 13 C NMR spectra were recorded at 300 MHz and 75 MHz respectively on a Varian Mercury 2000 spectrometer. Spectra were run in CDCl 3 unless otherwise stated. Chemical shifts are measured in ppm and referenced internally to residual CHCl 3 for 1 H NMR (δ 7.26) and the central peak of CDCl 3 for 13 C NMR (δ 77.16). Infrared spectra were recorded on a Perkin Elmer FT-IR Paragon 1000 spectrometer as thin films on NaCl plates unless otherwise stated. High resolution and low resolution mass spectrometry was performed on a Kratos Concept ISQ mass instrument. Flash chromatography was performed according to the method of Still and co-workers using silica gel 60 (32-63μm) [11] . Homoserine was made by a literature procedure [10] . All other solvents and reagents were available from Aldrich, AJAX or BDH Chemicals and used as supplied or purified by standard laboratory methods as required. Organic extracts were dried with anhydrous magnesium sulfate unless otherwise stated.
Ethyl 4-(1H-pyrrol-1-yl)pent-2-enoate (2)
A solution of methyl 2-(1H-pyrrol-1-yl)propanoate 1 (0.500 g, 3.26 mmol) in anhydrous dichloromethane (80 mL) under an atmosphere of nitrogen was cooled to -78ºC.
Diisobutyl aluminium hydride (DIBAL-H) (2.61 mL of a 1.5 M solution in toluene, 3.92 mmol) was then added to the reaction mixture drop-wise and the reaction stirred at this temperature for 45 min. In a separate flask triethyl phosphonoacetate (0.810 mL, 4.08 mmol) was added drop-wise to a suspension of sodium hydride (0.179 g, 4.47 mmol) in anhydrous tetrahydrofuran (THF) (25 mL) under nitrogen at 0 o C. The solution was cooled to -78 o C before transfer by cannula to the first reaction mixture. Stirring at -78ºC was continued for a further 30 min, then warmed to room temperature and stirred for a further 15 h. The reaction mixture was quenched with water (1 mL) then evaporated to dryness. Water (20 mL) was then added followed by 0.5 M aqueous potassium hydrogen sulphate until the solution was acidic (10 mL) and the aqueous solution extracted with dichloromethane (3 x 20 mL). The combined extracts were dried and the solvent removed to give the crude product. The product was purified by silica gel chromatography by elution with 10% ethyl acetatehexanes. The product 2 was isolated as a yellow oil in 73% yield (463 mg). 
IR

Ethyl 4-(1H-pyrrol-1-yl)pentanoate (3)
A solution of ethyl 4-(1H-pyrrol-1-yl)pent-2enoate 2 (256 mg, 1.33 mmol) in ethanol (10 mL) containing 20 mg of 5% w/w palladium on carbon was hydrogenated at 40 psi in a Parr shaker hydrogenator for 2 h. The reaction mixture was then filtered through a plug of silica gel with elution by 50% ethyl acetate-hexanes. The filtrate was concentrated by rotary evaporation to yield the product 3 as a clear oil in 97% yield (251 mg). IR: 2954, 2923, 2853, 1742, 1461, 1377, 722 cm -1 . 1 H NMR: 1.23 (3H, t, J = 7.2 Hz), 1.47 (3H, d, J = 6.9 Hz), 2.04 (4H, m), 4.10 (3H, q, J = 7.2), 4.11 (1H, m, obscured by q), 6.14 (2H, apparent t), 6.67 (2H, apparent t). 13 C NMR: 14.3 (CH 3 ), 22.3 (CH 3 ), 30.9 (CH 2 ), 33.3 (CH 2 ), 54.6 (CH), 60.5 (CH 2 ), 107.9 (CH), 118.5 (CH), 173.1 (C=O).
5-Methyl-6,7-dihydroindolizidin-8(5H)-one (4)
Boron tribromide (0.73 mL, 5.10 mmol) was added dropwise to a stirred solution of ethyl 4-(1H-pyrrol-1yl)pentanoate 3 (0.897 g, 4.64 mmol) in anhydrous dichloromethane (20 mL) under nitrogen at 0°C. The solution was stirred at this temperature for 10 min and was then quenched by the addition of water (10 mL) and 2 M sodium carbonate (10 mL). The organic layer was separated and the aqueous extracted with dichloromethane (2 x 20 mL). The combined organic extracts were then dried and filtered through silica gel with ethyl acetate as an eluent to yield 5-methyl-6,7-dihydroindolizidin-8(5H)-one 4 as a colorless solid in 94% yield (0.644 g): MP = 98-100ºC.
The spectral data were consistent with that reported previously [3] .
Ethyl 4-(1H-pyrrol-1-yl)hepanoate (6, R = n-C 3 H 7 )
The same procedure as used for 3 was followed with methyl 2-(1H-pyrrol-1-yl)pentanoate (5) 
5-Propyl-6,7-dihydroindolizidin-8(5H)-one (7, R = n-C 3 H 7 )
The γ-pyrrolic ester 6 (R = n-C 3 H 7 ) (0.103 g, 0.46 mmol) was cyclised under the same conditions as compound 3 to yield the bicyclic product 7 (R = n- The title compound was prepared as a pale yellow oil in >95% yield (3.35 g) from DL-norleucine methyl ester hydrochloride (3.123 g, 17.19 mmol) according to the literature procedure [4] . IR: 2957, 2863, 1747, 1489, 1438, 1278, 1173, 1092, 1024, 726, 619 cm -1 . 1 H NMR: 0.88 (3H, t, J = 6.9 Hz), 1.18 -1.28 (4H, m), 2.00 -2.16 (2H, m), 3.72 (3H, s), 4.55 (1H, dd, J 1 = 9.6 Hz, J 2 = 6 Hz), 6.18 (2H, apparent t), 6.75 (2H, apparent t). 13 C NMR: 13.9 (CH 3 ), 22.2 (CH 2 ), 28.0 (CH 2 ), 32.6 (CH 2 ), 52.5 (CH 3 The same procedure for 3 was followed to give (E)-ethyl 4-(1H-pyrrol-1-yl)oct-2-enoate as a clear oil from 5 (R = n-C 4 H 7 ) (2.0 g, 10.24 mmol) in 41% yield (0.994 g). .13 (2H, apparent t), 6.62 (2H, apparent t): 13 C NMR: 14.1 (CH 3 ), 14.4 (CH 3 ), 22.6 (CH 2 ), 28.6 (CH 2 ), 31.0 (CH 2 ), 31.9 (CH 2 ), 36.6 (CH 2 ), 59.8 (CH), 60.6 (CH 2 ), 108.0 (CH), 119.0 (CH), 173.4 (C=O).
5-Butyl-6,7-dihydroindolizidin-8(5H)-one (7, R = n-C 4 H 9 )
The γ-pyrrolic ester 6 (R = n-C 4 H 9 ) (0.491 g, 2.07 mmol) was cyclized under the same conditions as compound 3 to yield the bicyclic product 7 (R = n-C 4 H 9 ) as a pale yellow oil in quantitative yield (0.394 g). 
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3-(1H-pyrrol-1-yl)-dihydrofuran-2(3H)-one (14)
The title compound was prepared in 65% yield ( 
Ethyl 6-hydroxy-4-(1H-pyrrol-1-yl)hexanoate (16)
3-(1H-Pyrrol-1-yl)-dihydrofuran-2(3H)-one (0.180 g, 1.191 mmol) was chain homologated by the general procedure to give the crude alkene which was immediately hydrogenated to yield the alcohol 16 in 54% yield (0.146 g).
The compound was immediately taken through the next step without further purification. 
Ethyl 6-(methylsulfonyloxy)-4-(1H-pyrrol-1-yl) hexanoate (17)
A solution of alcohol 16 (0.146 g, 0.65 mmol) in CH 2 Cl 2 (5 mL) was treated with methanesulfonyl chloride (0.081 g, 0.71 mmol) and triethylamine (0.072 g, 0.71 mmol) at 0 ºC and stirred for 1h. After stirring it was washed with sodium bicarbonate (5 mL) then 1M HCl (5 mL). Column chromatography with 1:1 ethyl acetate/hexanes yielded the mesylate as a pale yellow oil in 45% yield (0.90 g). 1 H NMR: 1.20 (3H, t, J = 7.2 Hz), 2.02 -2.26 (6H, m), 2.89 (3H, s), 3.78 (1H, td, J 1 = 9.6 Hz, J 2 = 4.5 Hz), 4.03 -4.14 (4H, m), 6.13 (2H, apparent t), 6.62 (2H, apparent t). 13 C NMR: 14.2 (CH 3 ), 30.5 (CH 2 ), 31.4 (CH 2 ), 35.9 (CH 2 ), 37.1 (CH 3 ), 55.4 (CH), 60.6 (CH 2 ), 66.7 (CH 2 ), 108.7 (CH), 118.9 (CH), 172.8 (C=O).
Ethyl 4-(1H-pyrrol-1-yl)decanoate (18)
A solution of CuI (0.186 g, 0.98 mmol) in diethyl ether (20 mL) at -20ºC was treated with 2M n-butyl lithium (0.978 mL, 1.96 mmol). This solution was cooled to -60ºC then a solution of the mesylate 17 (0.074 g, 0.24 mmol) in ether was added. The reaction was stirred for 2.5 h before warming to room temperature. The reaction was quenched by addition of saturated NH 4 Cl solution (10 mL), and extracted with ether (3 x 10 mL) and concentrated by rotary evaporation. Column chromatography with 20% to 50% ethyl acetate in hexanes yielded the product as a pale yellow oil in 46% yield (0.030 g). IR: 2928, 2856, 1732, 1488, 1416, 1267, 1092, 1030, 727, 639 cm -1 . 1 H NMR: 0.85 (3H, t, J = 6.9 Hz), 1.18 -1.28 (11H, m), 1.66 -1.77 (2H, m), 1.92 -2.11 (4H, m), 3.76 -3.88 (1H, m), 4.09 (2H, q, J = 6.9 Hz), 6.13 (2H, apparent t), 6.62 (2H, apparent t). 13 C NMR: 14.2 (CH 3 ), 14.3 (CH 3 ), 22.7 (CH 2 ), 26.3 (CH 2 ), 29.1 (CH 2 ), 30.9 (CH 2 ), 31.8 (CH 2 ), 31.8 (CH 2 ), 36.8 (CH 2 ), 59.7 (CH), 60.5 (CH 2 ), 107.9 (CH), 118.9 (CH), 173.3 (C=O).
5-Hexyl-6,7-dihydroindolizidin-8(5H)-one (19)
The γ-pyrrolic ester 18 was cyclized under the standard conditions to yield the bicyclic product 19 as an oil in quantitative yield. The spectral data were consistent with that reported previously [3] .
